ERBB2 and breast carcinoma: A study utilizing the National Cancer Database identified breast pCR as ypT0/Tis, with observed ypN+ frequencies of 12.4% and 14.1% in patients with HER2-positive and HR-negative/HER2-negative breast cancer, respectively [12].